Ultra-hypofractionated adjuvant radiotherapy for breast cancer: evidence synthesis to support a generic justification decision
McGarry M, Dullea A, O'Sullivan L, O'Brien K, Carrigan M, Harrington P, Ryan M, Spillane D, Larkin L, O'Shea M, Walsh K
Record ID 32018005369
English
Authors' objectives:
This review was conducted in response to an application submitted by the St. Luke’s
Radiation Oncology Network in Dublin for the generic justification of ultrahypofractionated radiotherapy treatment in breast cancer. The target population
listed in the application for generic justification was patients undergoing adjuvant
radiotherapy, following breast conserving surgery or mastectomy.
Details
Project Status:
Completed
URL for project:
https://www.hiqa.ie/reports-and-publications/health-technology-assessment/ultra-hypofractionated-adjuvant-radiotherapy
Year Published:
2023
URL for published report:
https://www.hiqa.ie/sites/default/files/2023-11/ultra-hypofractionated-radiotherapy-for-the-treatment-of-breast-cancer.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Ireland
MeSH Terms
- Breast Neoplasms
- Radiation Dose Hypofractionation
- Radiotherapy, Adjuvant
Keywords
- Breast Cancer
- breast conserving surgery
- Ultra-hypofractionated radiotherapy
Contact
Organisation Name:
Health Information and Quality Authority (HIQA)
Contact Address:
Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name:
info@hiqa.ie
Contact Email:
info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.